Logo

Genedata Expands Collaboration with Altana

Jun 29, 2004

NEW YORK, June 29 (GenomeWeb News) - Genedata will continue to provide Altana Pharma with its scientific computational platform, the Basel, Switzerland-based company said today.

 

Under the expanded collaboration, Altana will use Genedata's platform for target identification, target validation, and lead discovery.

 

Altana first licensed the platform five years ago for its research sites in Constance, Germany, and Waltham, Mass.

 

Breaking News
The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.